Your browser doesn't support javascript.
loading
Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib.
Svaton, Martin; Fiala, Ondrej; Krakorova, Gabriela; Blazek, Jiri; Hurdalkova, Karolina; Barinova, Magda; Mukensnabl, Petr; Pesek, Milos.
Affiliation
  • Svaton M; Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic.
  • Fiala O; Department of Oncology and Radiotherapy, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic.
  • Krakorova G; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic.
  • Blazek J; Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic.
  • Hurdalkova K; Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic.
  • Barinova M; Institute of Biostatistics and Analyses Ltd., 625 00 Brno, Czech Republic.
  • Mukensnabl P; Institute of Biostatistics and Analyses Ltd., 625 00 Brno, Czech Republic.
  • Pesek M; Department of Pathology, Faculty of Medicine in Pilsen, Charles University, 305 99 Pilsen, Czech Republic.
Oncol Lett ; 20(2): 1376-1382, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32724380

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Oncol Lett Year: 2020 Type: Article Affiliation country: Czech Republic

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Oncol Lett Year: 2020 Type: Article Affiliation country: Czech Republic